Document is current

Any future updates will be listed below

Correction to: Combination efficacy of pertuzumab and trastuzumab for trastuzumab emtansine-resistant cells exhibiting attenuated lysosomal trafficking or efflux pumps upregulation

Crossref DOI link: https://doi.org/10.1007/s00280-020-04212-y

Published Online: 2020-12-18

Published Print: 2021-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark